Naimish Patel SEC EDGAR Filings (CIK 0002021679)

SEC EDGAR filings, ownership reports, and insider transactions for Naimish Patel.

Business address
C/O Crispr Therapeutics, 105 West First Street, Boston, MA, 02127
Top holdings (ownership)
CRSP
Get insider transactions for this reporting owner
Naimish Patel has filed 8 SEC EDGAR filings since 28 May 2024

Latest Filings

Recent SEC filings for Naimish Patel including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 4 27 Jan 2026 03 Apr 2025 001-37923
4 Open 4 document View SEC filing for 4 4 03 Oct 2025 03 Oct 2025 001-37923
4 Open 4 document View SEC filing for 4 4 03 Jun 2025 30 May 2025 001-37923
4 Open 4 document View SEC filing for 4 4 30 May 2025 28 May 2025 001-37923
4 Open 4 document View SEC filing for 4 4 18 Mar 2025 14 Mar 2025 001-37923
4 Open 4 document View SEC filing for 4 4 18 Oct 2024 16 Oct 2024 001-37923
4 Open 4 document View SEC filing for 4 4 29 May 2024 28 May 2024 001-37923
3 Open 3 document View SEC filing for 3 3 28 May 2024 28 May 2024 001-37923

About this filer

Naimish Patel files with the SEC under CIK 0002021679. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages